These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3190732)

  • 1. Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation.
    Braughler JM; Burton PS; Chase RL; Pregenzer JF; Jacobsen EJ; VanDoornik FJ; Tustin JM; Ayer DE; Bundy GL
    Biochem Pharmacol; 1988 Oct; 37(20):3853-60. PubMed ID: 3190732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate.
    Hamazaki S; Okada S; Li JL; Toyokuni S; Midorikawa O
    Arch Biochem Biophys; 1989 Jul; 272(1):10-7. PubMed ID: 2500058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of additional iron-chelators on Fe(2+)-initiated lipid peroxidation: evidence to support the Fe2+ ... Fe3+ complex as the initiator.
    Tang LX; Yang JL; Shen X
    J Inorg Biochem; 1997 Dec; 68(4):265-72. PubMed ID: 9397574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.
    Braughler JM; Pregenzer JF; Chase RL; Duncan LA; Jacobsen EJ; McCall JM
    J Biol Chem; 1987 Aug; 262(22):10438-40. PubMed ID: 3611075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of quinolinate on rat brain lipid peroxidation is dependent on iron.
    Stípek S; Stastný F; Pláteník J; Crkovská J; Zima T
    Neurochem Int; 1997 Feb; 30(2):233-7. PubMed ID: 9017671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lipid peroxidation by a new family of iron chelators. Comparison with desferrioxamine.
    Rachidi S; Coudray C; Baret P; Gelon G; Pierre JL; Favier A
    Biol Trace Elem Res; 1994; 41(1-2):77-87. PubMed ID: 7946911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibitory effects of chelating drugs on lipid peroxidation in rat brain homogenates.
    Kozlov AB; Ostrachovitch EA; Afanas'ev IB
    Biochem Pharmacol; 1994 Mar; 47(5):795-9. PubMed ID: 8135855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation and inhibition of iron-dependent lipid peroxidation by desferrioxamine.
    Braughler JM; Chase RL; Pregenzer JF
    Biochem Biophys Res Commun; 1988 Jun; 153(3):933-8. PubMed ID: 3390189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of in vitro lipid peroxidation by 21-aminosteroids. Evidence for differential mechanisms.
    Ryan TP; Steenwyk RC; Pearson PG; Petry TW
    Biochem Pharmacol; 1993 Sep; 46(5):877-84. PubMed ID: 8373438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal lipid peroxidation: mechanisms of initiation. The role of iron and iron chelators.
    Ursini F; Maiorino M; Hochstein P; Ernster L
    Free Radic Biol Med; 1989; 6(1):31-6. PubMed ID: 2492247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 21-aminosteroidlike compounds prevent iron-induced free radical-mediated injury to vascular endothelial cells.
    Pakala R; Pakala R; Benedict CR
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):871-9. PubMed ID: 7564331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
    Santos NC; Castilho RF; Meinicke AR; Hermes-Lima M
    Eur J Pharmacol; 2001 Sep; 428(1):37-44. PubMed ID: 11779035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by Fe2+-citrate.
    Andreu GP; Delgado R; Velho JA; Curti C; Vercesi AE
    Eur J Pharmacol; 2005 Apr; 513(1-2):47-55. PubMed ID: 15878708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of cultured rat gastric cells against oxidant stress by iron chelation. Role of lipid peroxidation.
    Yajima N; Hiraishi H; Harada T
    Dig Dis Sci; 1995 Apr; 40(4):879-86. PubMed ID: 7720485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation of rat erythrocyte membrane induced by adriamycin-Fe3+.
    Miura T; Muraoka S; Ogiso T
    Pharmacol Toxicol; 1991 Oct; 69(4):296-300. PubMed ID: 1659698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox cycling of iron and lipid peroxidation.
    Minotti G; Aust SD
    Lipids; 1992 Mar; 27(3):219-26. PubMed ID: 1326072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenton reagents may not initiate lipid peroxidation in an emulsified linoleic acid model system.
    Yin D; Lingnert H; Ekstrand B; Brunk UT
    Free Radic Biol Med; 1992 Nov; 13(5):543-56. PubMed ID: 1459478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of deferrioxamine on iron-catalyzed lipid peroxidation.
    Miller DM; Spear NH; Aust SD
    Arch Biochem Biophys; 1992 Jun; 295(2):240-6. PubMed ID: 1586153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-dependent peroxidation of rat brain: a regional study.
    Subbarao KV; Richardson JS
    J Neurosci Res; 1990 Jun; 26(2):224-32. PubMed ID: 2366265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.